Iterum Therapeutics
(ITRM)
undefined
undefined%
At close: undefined
2.03
2.78%
Pre-market Jan 07, 2025, 04:18 AM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| PE Ratio | -0.67 | -0.23 | -10.49 | -6.85 | -9.5 | -0.57 | -3.32 | -7.25 |
| PS Ratio | n/a | n/a | n/a | n/a | 26.49K | 50.35 | 192.10 | n/a |
| PB Ratio | -3.99 | 0.37 | 19.12 | -7.05 | -37.35 | 0.61 | 2.47 | 4.31 |
| P/FCF Ratio | -0.65 | -0.55 | -60.4 | -6.53 | -12.42 | -0.58 | -3.11 | -8.64 |
| P/OCF Ratio | -0.65 | -0.56 | -60.64 | -6.53 | -12.42 | -0.58 | -3.19 | -8.64 |
| OCF/S Ratio | n/a | n/a | n/a | n/a | -2.13K | -87.33 | -60.24 | n/a |
| Debt / Equity Ratio | -2.96 | 1.02 | 0.53 | -0.84 | -0.51 | 0.20 | n/a | n/a |
| Quick Ratio | 1.89 | 319.84 | 13.94 | 0.63 | 0.35 | 7.57 | 6.20 | 6.13 |
| Current Ratio | 1.89 | 310.40 | 13.43 | 0.50 | 0.13 | 6.93 | 6.20 | 6.13 |
| Asset Turnover | n/a | n/a | n/a | n/a | 0.00 | 0.01 | 0.01 | n/a |
| Interest Coverage | n/a | -12.87 | -4.42 | -2.13 | -118.49 | -179.72 | n/a | n/a |
| Return on Equity (ROE) | 5.99 | -1.59 | -1.82 | 1.03 | 3.93 | -1.08 | -0.74 | -0.59 |
| Return on Assets (ROA) | -1.46 | -0.66 | -1 | -1.59 | -4 | -0.79 | -0.63 | -0.5 |
| Return on Capital (ROIC) | -3.73 | -0.46 | -0.29 | -8.18 | 9.08 | -0.89 | -0.74 | -0.59 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | n/a | 100.00% | 100.00% | 100.00% | n/a |
| Net Profit Margin | n/a | n/a | n/a | n/a | -278.73K% | -8.87K% | -5.79K% | n/a |
| Pretax Profit Margin | n/a | n/a | n/a | n/a | -277.53K% | -8.81K% | -5.70K% | n/a |
| Operating Profit Margin | n/a | n/a | n/a | n/a | -275.73K% | -8.81K% | -5.80K% | n/a |
| FCF Margin | n/a | n/a | n/a | n/a | -213.27K% | -8.74K% | -6.18K% | n/a |
| EBITDA Margin | n/a | n/a | n/a | n/a | -274.79K% | -8.75K% | -5.79K% | n/a |